Skip to content
10-K

Annual Report

HAEMONETICS CORPORATION HAE

0000313143-26-000050

← back to feed
Filed
May 20, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2026 · May 15, 2026 45.45M sh
Shares Diluted FY 2026 · Mar 28, 2026 47.35M sh
Shares Diluted FY 2026 · Mar 29, 2025 50.73M sh
Shares Diluted FY 2026 · Mar 30, 2024 51.4M sh
Stock Repurchased FY 2026 · Mar 28, 2026 $175M
Stock Repurchased FY 2026 · Mar 29, 2025 $225M
Stock Repurchased FY 2026 · Mar 30, 2024 $0
Capex FY 2026 · Mar 28, 2026 $32.78M
Capex FY 2026 · Mar 29, 2025 $39.28M
Capex restated FY 2026 · Mar 30, 2024 $38.13M
Operating Cash Flow FY 2026 · Mar 28, 2026 $293.22M
Operating Cash Flow FY 2026 · Mar 29, 2025 $181.73M
Operating Cash Flow FY 2026 · Mar 30, 2024 $181.75M
Long Term Debt FY 2026 · Mar 28, 2026 $1.22B
Long Term Debt FY 2026 · Mar 29, 2025 $921.23M
Cash And Equivalents FY 2026 · Mar 28, 2026 $245.44M
Cash And Equivalents FY 2026 · Mar 29, 2025 $306.76M
Stockholders Equity FY 2026 · Mar 28, 2026 $796.32M
Stockholders Equity FY 2026 · Mar 29, 2025 $820.84M
Stockholders Equity FY 2026 · Mar 30, 2024 $959.96M
Stockholders Equity FY 2026 · Apr 1, 2023 $818M
Current Liabilities FY 2026 · Mar 28, 2026 $282.6M
Current Liabilities FY 2026 · Mar 29, 2025 $578.11M
Current Assets FY 2026 · Mar 28, 2026 $834.88M
Current Assets FY 2026 · Mar 29, 2025 $934.98M
Total Assets FY 2026 · Mar 28, 2026 $2.4B
Total Assets FY 2026 · Mar 29, 2025 $2.45B
Eps Diluted FY 2026 · Mar 28, 2026 $2.05
Eps Diluted FY 2026 · Mar 29, 2025 $3.31
Eps Diluted FY 2026 · Mar 30, 2024 $2.29
Eps Basic FY 2026 · Mar 28, 2026 $2.06
Eps Basic FY 2026 · Mar 29, 2025 $3.33
Eps Basic FY 2026 · Mar 30, 2024 $2.32
Sga Expense FY 2026 · Mar 28, 2026 $442.42M
Sga Expense FY 2026 · Mar 29, 2025 $436.79M
Sga Expense restated FY 2026 · Mar 30, 2024 $429.78M
Rd Expense FY 2026 · Mar 28, 2026 $59.77M
Rd Expense FY 2026 · Mar 29, 2025 $62.72M
Rd Expense FY 2026 · Mar 30, 2024 $54.44M
Net Income FY 2026 · Mar 28, 2026 $97.31M
Net Income FY 2026 · Mar 29, 2025 $167.68M
Net Income FY 2026 · Mar 30, 2024 $117.56M
Operating Income FY 2026 · Mar 28, 2026 $156.73M
Operating Income FY 2026 · Mar 29, 2025 $221.82M
Operating Income FY 2026 · Mar 30, 2024 $164.88M
Gross Profit FY 2026 · Mar 28, 2026 $787.59M
Gross Profit FY 2026 · Mar 29, 2025 $748.96M
Gross Profit FY 2026 · Mar 30, 2024 $691.55M
Cost Of Revenue FY 2026 · Mar 28, 2026 $546.44M
Cost Of Revenue FY 2026 · Mar 29, 2025 $611.87M
Cost Of Revenue FY 2026 · Mar 30, 2024 $617.51M
Revenue FY 2026 · Mar 28, 2026 $1.33B
Revenue FY 2026 · Mar 29, 2025 $1.36B
Revenue FY 2026 · Mar 30, 2024 $1.31B